Walsh Tom P, Merlo Greg B, Rutter Cameron, Abell Bridget, Platt Simon R, Arnold John B
Queensland University of Technology, Kelvin Grove, Queensland, Australia.
University of Queensland, Herston, Queensland, Australia.
Arthritis Care Res (Hoboken). 2022 Apr;74(4):626-637. doi: 10.1002/acr.24514. Epub 2022 Mar 9.
Musculoskeletal conditions of the foot and ankle are common, yet the cost-effectiveness of the variety of treatments available is not well defined. The aim of this systematic review was therefore to identify, appraise, and synthesize the literature pertaining to the cost-effectiveness of interventions for musculoskeletal foot and ankle conditions.
Electronic databases were searched for studies presenting economic evaluations of nonsurgical and surgical treatments for acute or chronic musculoskeletal conditions of the foot and ankle. Data on cost, incremental cost-effectiveness, and quality-adjusted life years for each intervention and comparison were extracted. Risk of bias was assessed using the Drummond checklist for economic studies (range 0-35).
Thirty-six studies were identified reporting nonsurgical interventions (n = 10), nonsurgical versus surgical interventions (n = 14), and surgical interventions (n = 12). The most common conditions were osteoarthritis, ankle fracture, and Achilles tendon rupture. The strongest economic evaluations were for interventions managing end-stage ankle osteoarthritis, ankle sprain, ankle fracture, calcaneal fracture, and Achilles tendon rupture. Total ankle replacement and ankle arthrodesis for end-stage ankle osteoarthritis, in particular, have been demonstrated through high-quality studies to be cost-effective compared to the nonsurgical alternative.
Selected interventions for musculoskeletal foot and ankle conditions dominate comparators, whereas others require thoughtful consideration as they provide better clinical improvements, but at an increased cost. Researchers should consider measuring and reporting costs alongside clinical outcome to provide context when determining the appropriateness of interventions for other foot and ankle symptoms to best inform future clinical practice guidelines.
足踝部的肌肉骨骼疾病很常见,但现有各种治疗方法的成本效益尚未明确界定。因此,本系统评价的目的是识别、评估和综合有关足踝部肌肉骨骼疾病干预措施成本效益的文献。
检索电子数据库,查找有关足踝部急性或慢性肌肉骨骼疾病非手术和手术治疗的经济评价研究。提取每种干预措施及对照的成本、增量成本效益和质量调整生命年的数据。使用经济研究的德拉蒙德清单(范围0-35)评估偏倚风险。
共识别出36项研究,报告了非手术干预措施(n = 10)、非手术与手术干预措施对比(n = 14)以及手术干预措施(n = 12)。最常见的疾病是骨关节炎、踝关节骨折和跟腱断裂。最强有力的经济评价针对的是终末期踝关节骨关节炎、踝关节扭伤、踝关节骨折、跟骨骨折和跟腱断裂的干预措施。特别是,通过高质量研究已证明,与非手术替代方案相比,终末期踝关节骨关节炎的全踝关节置换和踝关节融合术具有成本效益。
针对足踝部肌肉骨骼疾病的某些选定干预措施优于对照措施,而其他一些措施则需要深思熟虑,因为它们能提供更好的临床改善,但成本更高。研究人员在确定其他足踝部症状干预措施的适用性时,应考虑同时测量和报告成本及临床结果,以便为未来临床实践指南提供参考依据。